Combining prestroke treatments reduces stroke severity
This article has no abstract so we have provided the first paragraph of the full text.
Antiplatelet agents, angiotensin-converting-enzyme inhibitors and statins are well known to be effective in stroke prevention. A retrospective study by researchers at the Beth Israel Deaconess Medical Center has shown that, if these drugs are used in combination prior to stroke, stroke severity might be reduced further and the volume of ischemic tissue at risk decreased.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.